Irinotecan HCl is an anti-tumor drug that is often employed in chemotherapy and ADC drug development. Its active metabolite, SN38, acts as a DNA topoisomerase I inhibitor, halting DNA synthesis and causing single-strand breaks in DNA.
Usually ships within 24 hours.